Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Medtronic
Federal Trade Commission
Citi
Chinese Patent Office
Harvard Business School

Generated: April 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,264,987

« Back to Dashboard

Which drugs does patent 6,264,987 protect, and when does it expire?

Patent 6,264,987 protects VIVITROL and is included in one NDA.

This patent has nineteen patent family members in eleven countries.

Summary for Patent: 6,264,987
Title: Method for preparing microparticles having a selected polymer molecular weight
Abstract:A method for preparing microparticles having a selected polymer molecular weight. The hold time and temperature of a solution containing a nucleophilic compound and a polymer having a starting molecular weight are controlled in order to control the molecular weight of the polymer in the finished microparticle product. In this manner, a selected polymer molecular weight in the finished microparticle product can be achieved from a variety of starting material molecular weights.
Inventor(s): Wright; Steven G. (Madeira, OH), Rickey; Michael E. (Loveland, OH), Ramstack; J. Michael (Lebanon, OH), Lyons; Shawn L. (Cincinnati, OH), Hotz; Joyce M. (Cincinnati, OH)
Assignee: Alkermes Controlled Therapeutics Inc. II (Cambridge, MA)
Application Number:09/575,075
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,264,987
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,264,987
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 6,264,987

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alkermes VIVITROL naltrexone FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 021897-001 Apr 13, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Julphar
Fish and Richardson
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.